Close Menu

Purdue University chemist David Nichols says he never intended for the compounds he invented to become harmful street drugs, reports the Associated Press's Seth Borenstein. Chemicals Nichols made as possible treatments to Parkinson's disease or depression, and which were roughly similar to ecstasy and LSD, have been exploited by black market labs as recreational drugs instead, Borenstein says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.